PMS2 Expression With Combination of PD-L1 and TILs for Predicting Survival of Esophageal Squamous Cell Carcinoma

PMS2 Expression With Combination of PD-L1 and TILs for Predicting Survival of Esophageal Squamous Cell Carcinoma

BackgroundDNA mismatch repair (MMR) deficiency (dMMR) has been recognized as an important biomarker for immunotherapy in esophageal squamous cell carcinoma (ESCC), along with programmed death ligand 1 (PD-L1) expression and/or tumor-infiltrated lymphocytes (TILs). However, in ESCC, MMR protein asses...

Full description

Bibliographic Details
Main Authors: Dongxian Jiang, Qi Song, Xiaojun Wei, Zixiang Yu, Yufeng Liu, Haixing Wang, Xingxing Wang, Jie Huang, Jieakesu Su, Yang Hong, Yifan Xu, Chen Xu, Yingyong Hou
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-07-01
Series:Frontiers in Oncology
Subjects:
DNA mismatch repair protein
PMS2
prognosis
PD-L1
TILs
esophageal squamous cell carcinoma (ESCC)
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.897527/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.897527/full

Similar Items